According to Alexandria Real Estate Equities 's latest financial reports the company's current EPS (TTM) is $1.39. In 2022 the company made an earnings per share (EPS) of $3.13 a decrease over its 2021 EPS that were of $3.79.
Year | EPS | Change |
---|---|---|
2023 (TTM) | $1.39 | -55.59% |
2022 | $3.13 | -17.41% |
2021 | $3.79 | -35.32% |
2020 | $5.86 | 89.03% |
2019 | $3.10 | -12.68% |
2018 | $3.55 | 124.68% |
2017 | $1.58 | -179% |
2016 | -$2.00 | -221.95% |
2015 | $1.64 | 62.38% |
2014 | $1.01 | -36.88% |
2013 | $1.60 | 46.79% |
2012 | $1.09 | -36.63% |
2011 | $1.72 | -20.74% |
2010 | $2.17 | -21.66% |
2009 | $2.77 | -3.48% |
2008 | $2.87 | 8.3% |
2007 | $2.65 | 16.23% |
2006 | $2.28 | 0.88% |
2005 | $2.26 | -9.27% |
2004 | $2.49 | -23.36% |
2003 | $3.25 | 81.56% |
2002 | $1.79 | 7.19% |
2001 | $1.67 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
Pfizer PFE | $1.86 | 33.81% | ๐บ๐ธ USA |
Eli Lilly LLY | $5.43 | 290.60% | ๐บ๐ธ USA |
Amgen AMGN | $14.15 | 917.99% | ๐บ๐ธ USA |
Gilead Sciences GILD | $4.39 | 215.83% | ๐บ๐ธ USA |
Illumina ILMN | -$26.61 | -2,014.39% | ๐บ๐ธ USA |
Bristol-Myers Squibb BMY | $3.97 | 185.61% | ๐บ๐ธ USA |
Alnylam Pharmaceuticals
ALNY | -$4.11 | -395.68% | ๐บ๐ธ USA |